Marijuana Market: Top Pot Stock Winners and Losers of the Week

Marijuana stock

Marijuana Winners and Losers of the Week

The marijuana market is hardly ever predictable. Maybe that’s not fair. It is predictable over long hauls, but short-term spans of days and weeks can be volatile. That’s to be expected when you’re playing an emerging market. Stocks shoot up with bold abandon, only to fall back to earth a few short weeks later. In aggregate, the prices are rising and will likely rise for years to come. But day-to-day, it’s a whole different ballgame.

As such, I’ve gone through the trouble of gathering together the top marijuana stock winners of the week…and the top marijuana stock losers of the week.

An important caveat here is that just because a stock is down today doesn’t mean it’ll stay that way tomorrow. Especially this past week, when the industry suffered a mass correction, with many of the top marijuana stocks taking large dips in value.

These corrections are to be expected and shouldn’t dissuade investors. Or at least, not until they cease to be blips and turn into a full-on downturn. But we’re still a ways away from a true industry dip, in my view.


With all that in mind, let’s get to the top marijuana stock winners of the week.

Top Marijuana Stock Winners of the Week

National Access Cannabis Corp

National Access Cannabis Corp (OTCMKTS:NACNF), (CVE: NAC) is one of the few marijuana stocks that was able to make it out of last week with strong gains. In fact, over the past week and into this one, NACNF stock has jumped by about 21%. Not too shabby for seven day’s trading.

National Access Cannabis operates an online medical marijuana business out of Canada. Patients can sign up, consult with a physician, and have their drug shipped to them, all through the convenience of an online portal.

National Access Cannabis stock chart

Chart courtesy of

In recent news, the provincial government of Manitoba selected National Access as one of four companies to receive a license to operate privately owned retail cannabis stores last week.

This is an obvious boon to the company, especially considering Canada’s growing reputation as one of the most weed-friendly countries in the world. With recreational marijuana legalization around the corner in Canada (even if it’s delayed), this bit of good news helped propel NACNF stock to a great week.

“With our history in successfully operating nationwide medical cannabis clinics, strong First Nations and Licensed Producer relationships, combined with our deep knowledge of safety, security, and harm reduction, NAC is perfectly suited to exceed Manitoba’s current and future cannabis retail regulatory requirements,” said Mark Goliger, Chief Executive Officer of NAC, in a statement. (Source: “National Access Cannabis Announces Successful Response to Manitoba Private Cannabis Industry RFP,” Cision, February 16, 2018.)

“With the Province’s decision today, Manitobans will have responsible, secure access to recreational marijuana once legalization occurs. We’re excited about our company’s future in recreational marijuana distribution and I look forward to providing you with updates as we develop these new locations.”

National Access Cannabis (NAC) Stock Forecast: I expect NANCF to continue to perform well over the next week, provided there’s no market-wide correction.

Organigram Holdings Inc

Organigram Holdings Inc (OTCMKTS:OGRMF), (CVE:OGI) is another one of the select few marijuana stocks that were able to have a strong week, despite so many other companies in the industry faltering.

With over 8.5% in gains over the past week into this one, OGRMF stock had a strong showing in mid-February.

The company, which prides itself on its high-quality products, also racked up some good news with the announcement of an expanded cultivation license from Health Canada relating to its Phase 2 expansion.

Organigram Holdings Inc stock chart

Chart courtesy of

Basically, what this means is that the government of Canada approved its plans for a new facility, adding approximately 150,000 square feet to the perimeter, as well as permission to build cultivation rooms and an improved design overall for the site.

The plan is for Phase 2 to yield an additional 10,800 kilograms a year when all is said and done. That would effectively triple the company’s output from 5,200 to 16,000.

“This is an important moment for Organigram” said CEO Greg Engel in a statement. “We’ve spent years perfecting three-level growing technology. We have developed a world-class cannabis production facility and are proud to be able to offer our medical and adult recreational customers exceptional award winning, high quality product in 2018 and beyond.” (Source: “Organigram Receives Expanded Cultivation License,” Cision, February 12, 2018.)

The company plans for Phase 3 and Phase 4 expansions, hoping to reach an annual production of 65,000 kilograms within the next two years.

Organigram Holdings (OGI) Stock Forecast: The company appears to have all its ducks in a row for continued gains, but I’m wary that next week may not be as positive as this one was.

Canopy Growth Corp

Canopy Growth Corp (OTCMKTS:TWMJF), (TSE:WEED) is one of the few larger companies that were able to get through last week with strong gains.

The company jumped a hair under eight percent between last week and today.

Aside from the gains, Canopy also had a major piece of news break on Wednesday: It signed a supply agreement with Sunniva Inc. (OTCMKTS:SNNVF).

Canopy Growth Corp Stock Chart

Chart courtesy of

The two-year agreement will see Canopy Growth purchase up to 90,000 kilograms of dried cannabis from Sunniva.

“We welcome Sunniva to the Canopy Growth family and look forward to collaborating with their team to provide a steady and high-quality source of cannabis products for consumers,” said Mark Zekulin, President, Canopy Growth, in a statement. (Source: “Canopy Growth Signs Significant Supply and Sales Agreement with Sunniva Medical Inc,” Cision, February 21, 2018.)

“Through provincial distribution channels, brick and mortar locations, and our online Tweed Main Street e-commerce platform we are diversifying our ability to deliver a one-stop shopping experience to consumers and provincial bodies alike. With partners like Sunniva, we are well positioned to capture market share through robust supply channels.”

Sunniva is also developing a 700,000 square foot greenhouse facility in British Columbia in order to help it meet its supply goals, adding more shine to this deal.

Canopy Growth (WEED) Stock Forecast: Canopy is the dominant force in the market. Therefore, in the long term, I’m bullish on Canopy Growth stock. Next week could go either way, but the company is in a strong position to perform well for the foreseeable future.

Top Marijuana Losers of the Week

Aphria Inc (OTCMKTS:APHQF) , (TSE:APH) was one of the harder hit companies last week, dropping about nine percent.

The industry as a whole had a rough go of it in mid-February. The marijuana market has been up and down since January, when we saw massive climbs of triple digits in some cases, only for a sizable chunk of those gains to be given back as January progressed.

Aphria is currently in the midst of a deal to acquire Nuuvera Inc (OTCMKTS:NUUVF), (CVE:NUU), but in an unusual move, came to an agreement with the company to lower the acquisition cost from $1.00 to $0.60 per share.

Aphria Inc Stock Chart

Chart courtesy of

The deal has not helped either company’s stock grow, with both taking hits since it was announced in late January.

I’m normally bullish on companies that seek to make smart acquisitions, especially Canadian marijuana businesses that are in dominant market positions and are gobbling up smaller competitors in preparation for legalization.

Still, the deal between Nuuvera and Aphria has not helped either company’s value, and we’ll see if that has more to do with trouble in the industry of late or specific workings of the deal.

Aphria (APH) Stock Forecast: I’m normally bullish on APHQF stock, but the most recent troubles with the Nuuvera deal has given me pause. I’d be cautious on Aphria until this deal gets sorted, but then expect the stock to bounce back.

Nuuvera Inc

As you could have guessed from the previous section, Nuuvera has been one of the bigger disappointments over the past week.

The company has dropped almost 15% over that period.

Part of the reason that Nuuvera claimed to agree to the new reduced-price deal with Aphria is that it is looking to fully acquire its subsidiary, Avanti Rx Analytics.

The strange part is that receiving less money is not going to make an acquisition more doable. It’s a bizarre nugget in this deal that is perhaps part of the reason both companies are suffering on the market.

Nuuvera Inc Stock Chart

Chart courtesy of

Nuuvera is looking to purchase the remaining 49% of Avanti for an estimated CA$43.0 million.

“The acquisition of Avanti is an important step in the history of Nuuvera and is expected to result in synergies at the combined Nuuvera/Aphria which will enhance the value of the arrangement to shareholders of Nuuvera,” said Ronald Schmeichel, Nuuvera’s chairman, in a statement. (Source: “Aphria reduces cash in bid for Nuuvera,” CBC, February 20, 2018.)

The original agreement between Aphria and Nuuvera was valued at CA$826.0 million, according to a late January release from the companies. The new deal has been reduced heavily to a value of CA$447.9 million.

The revised deal will see Aphria offer CA$0.60 in cash in addition to 0.3546 of an Aphria share.

Nuuvera (NUU) Stock Forecast: Similar to above. While I’m not as high on Nuuvera as Aphria, it’s still a solid company most times. The strange moves around the multiple acquisitions are doing the stock no favors, however, so investors may want to steer clear until the deals are resolved.

Radient Technologies Inc

Radient Technologies Inc (OTCMKTS:RDDTF), (CVE:RTI), a company that manufacturers cannabis extracts, is the final addition to our list of marijuana’s biggest losers last week.

The company has had a tough time on the market of late, seeing its gains flat-line over the past several months while other companies have seen massive jumps in value.

Radient fell by about 8.5% in the past week, despite good news coming out in early February regarding a licensing deal with the Canadian government.

Radient Technologies Stock Chart

Chart courtesy of

Health Canada approved its application for the Controlled Drugs and Substances License. This will allow the company to possess, package, and transport cannabis products at its laboratory in Edmonton.

Despite this boon, the company has still been unable to see strong gains of late.

Radient Technologies (RTI) Stock Forecast: Radient has not had a good go of it in 2018, and I’m not sure that’s going to change anytime soon. The recent spate of good news did little to redeem the stock, so I’m bearish on Radient at the moment.

Analyst Take

This was an interesting and volatile week for the marijuana industry, with big gains and losses and massive shifts in fortune from one day to the next. Still, that volatility is what brings so many investors to the table in the first place. Big rewards are not often won without big risk, after all.